These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25565157)

  • 21. [Antisense oligonucleotides for therapy of cystic fibrosis. Inhibition of sodium absorption mediated by ENaC in nasal epithelial cells].
    Sobczak K; Bangel-Ruland N; Semmler J; Lindemann H; Heermann R; Weber WM
    HNO; 2009 Nov; 57(11):1106-12. PubMed ID: 19727627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical evaluation of the epithelial sodium channel inhibitor AZD5634 and implications on human translation.
    Åstrand A; Libby EF; Shei RJ; Lever JEP; Kaza N; Adewale AT; Boitet E; Edwards L; Hemmerling M; Root J; Lindberg B; Wingren C; Malmgren A; Sabater J; Rowe SM
    Am J Physiol Lung Cell Mol Physiol; 2022 Nov; 323(5):L536-L547. PubMed ID: 36098422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of airway mucosal hydration.
    Paisley D; Gosling M; Danahay H
    Expert Rev Clin Pharmacol; 2010 May; 3(3):361-9. PubMed ID: 22111616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPX-101 is stable in and retains function after exposure to cystic fibrosis sputum.
    Sesma JI; Wu B; Stuhlmiller TJ; Scott DW
    J Cyst Fibros; 2019 Mar; 18(2):244-250. PubMed ID: 29936069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
    Mall MA
    Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice.
    Crosby JR; Zhao C; Jiang C; Bai D; Katz M; Greenlee S; Kawabe H; McCaleb M; Rotin D; Guo S; Monia BP
    J Cyst Fibros; 2017 Nov; 16(6):671-680. PubMed ID: 28539224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of neutrophil elastase and its inhibitor EPI-hNE4 on transepithelial sodium transport across normal and cystic fibrosis human nasal epithelial cells.
    Prulière-Escabasse V; Clerici C; Vuagniaux G; Coste A; Escudier E; Planès C
    Respir Res; 2010 Oct; 11(1):141. PubMed ID: 20932306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thickness of the airway surface liquid layer in the lung is affected in cystic fibrosis by compromised synergistic regulation of the ENaC ion channel.
    Olivença DV; Fonseca LL; Voit EO; Pinto FR
    J R Soc Interface; 2019 Aug; 16(157):20190187. PubMed ID: 31455163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways.
    Garland AL; Walton WG; Coakley RD; Tan CD; Gilmore RC; Hobbs CA; Tripathy A; Clunes LA; Bencharit S; Stutts MJ; Betts L; Redinbo MR; Tarran R
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):15973-8. PubMed ID: 24043776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-content siRNA screen reveals global ENaC regulators and potential cystic fibrosis therapy targets.
    Almaça J; Faria D; Sousa M; Uliyakina I; Conrad C; Sirianant L; Clarke LA; Martins JP; Santos M; Heriché JK; Huber W; Schreiber R; Pepperkok R; Kunzelmann K; Amaral MD
    Cell; 2013 Sep; 154(6):1390-400. PubMed ID: 24034256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
    Zhang LN; Karp P; Gerard CJ; Pastor E; Laux D; Munson K; Yan Z; Liu X; Godwin S; Thomas CP; Zabner J; Shi H; Caldwell CW; Peluso R; Carter B; Engelhardt JF
    Mol Ther; 2004 Dec; 10(6):990-1002. PubMed ID: 15564131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures.
    Hobbs CA; Blanchard MG; Alijevic O; Tan CD; Kellenberger S; Bencharit S; Cao R; Kesimer M; Walton WG; Henderson AG; Redinbo MR; Stutts MJ; Tarran R
    Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(12):L990-L1001. PubMed ID: 24124190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in cystic fibrosis.
    Myerburg MM; Butterworth MB; McKenna EE; Peters KW; Frizzell RA; Kleyman TR; Pilewski JM
    J Biol Chem; 2006 Sep; 281(38):27942-9. PubMed ID: 16873367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease.
    Hirsh AJ; Zhang J; Zamurs A; Fleegle J; Thelin WR; Caldwell RA; Sabater JR; Abraham WM; Donowitz M; Cha B; Johnson KB; St George JA; Johnson MR; Boucher RC
    J Pharmacol Exp Ther; 2008 Apr; 325(1):77-88. PubMed ID: 18218832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung.
    Tagalakis AD; Munye MM; Ivanova R; Chen H; Smith CM; Aldossary AM; Rosa LZ; Moulding D; Barnes JL; Kafetzis KN; Jones SA; Baines DL; Moss GWJ; O'Callaghan C; McAnulty RJ; Hart SL
    Thorax; 2018 Sep; 73(9):847-856. PubMed ID: 29748250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral localization of the epithelial sodium channel in the apical membrane of bronchial epithelial cells.
    Musante I; Scudieri P; Venturini A; Guidone D; Caci E; Castellani S; Conese M; Galietta LJV
    Exp Physiol; 2019 Jun; 104(6):866-875. PubMed ID: 30924990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis: a disease of vulnerability to airway surface dehydration.
    Boucher RC
    Trends Mol Med; 2007 Jun; 13(6):231-40. PubMed ID: 17524805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
    Knowles MR; Olivier K; Noone P; Boucher RC
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S65-9. PubMed ID: 7533608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered mutant α-ENaC subunit mRNA delivered by lipid nanoparticles reduces amiloride currents in cystic fibrosis-based cell and mice models.
    Mukherjee A; MacDonald KD; Kim J; Henderson MI; Eygeris Y; Sahay G
    Sci Adv; 2020 Nov; 6(47):. PubMed ID: 33208364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glandular Proteome Identifies Antiprotease Cystatin C as a Critical Modulator of Airway Hydration and Clearance.
    Evans TI; Joo NS; Keiser NW; Yan Z; Tyler SR; Xie W; Zhang Y; Hsiao JJ; Cho HJ; Wright ME; Wine JJ; Engelhardt JF
    Am J Respir Cell Mol Biol; 2016 Apr; 54(4):469-81. PubMed ID: 26334941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.